Transient akathisia after the SARS-Cov-2 vaccine

We describe a case of transient akathisia after the second dose of the Pfizer COVID-19 vaccine. Movement disorder symptoms such as parkinsonism have been described after other vaccinations and acute COVID-19 infection. This suggests a potential vulnerability of the extrapyramidal system to the immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Salinas, Meagen R., Dieppa, Marisara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Correspondence (including Letter to the Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178529/
https://www.ncbi.nlm.nih.gov/pubmed/34113842
http://dx.doi.org/10.1016/j.prdoa.2021.100098
_version_ 1783703587655778304
author Salinas, Meagen R.
Dieppa, Marisara
author_facet Salinas, Meagen R.
Dieppa, Marisara
author_sort Salinas, Meagen R.
collection PubMed
description We describe a case of transient akathisia after the second dose of the Pfizer COVID-19 vaccine. Movement disorder symptoms such as parkinsonism have been described after other vaccinations and acute COVID-19 infection. This suggests a potential vulnerability of the extrapyramidal system to the immune response against even a component of the virus.
format Online
Article
Text
id pubmed-8178529
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-81785292021-06-05 Transient akathisia after the SARS-Cov-2 vaccine Salinas, Meagen R. Dieppa, Marisara Clin Park Relat Disord Correspondence (including Letter to the Editor) We describe a case of transient akathisia after the second dose of the Pfizer COVID-19 vaccine. Movement disorder symptoms such as parkinsonism have been described after other vaccinations and acute COVID-19 infection. This suggests a potential vulnerability of the extrapyramidal system to the immune response against even a component of the virus. Elsevier 2021-06-05 /pmc/articles/PMC8178529/ /pubmed/34113842 http://dx.doi.org/10.1016/j.prdoa.2021.100098 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Correspondence (including Letter to the Editor)
Salinas, Meagen R.
Dieppa, Marisara
Transient akathisia after the SARS-Cov-2 vaccine
title Transient akathisia after the SARS-Cov-2 vaccine
title_full Transient akathisia after the SARS-Cov-2 vaccine
title_fullStr Transient akathisia after the SARS-Cov-2 vaccine
title_full_unstemmed Transient akathisia after the SARS-Cov-2 vaccine
title_short Transient akathisia after the SARS-Cov-2 vaccine
title_sort transient akathisia after the sars-cov-2 vaccine
topic Correspondence (including Letter to the Editor)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178529/
https://www.ncbi.nlm.nih.gov/pubmed/34113842
http://dx.doi.org/10.1016/j.prdoa.2021.100098
work_keys_str_mv AT salinasmeagenr transientakathisiaafterthesarscov2vaccine
AT dieppamarisara transientakathisiaafterthesarscov2vaccine

Ejemplares similares